TY  - RPRT
TI  - The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas
AU  - Cleverley, T.
AU  - Peddineni, S.
AU  - Guarner, J.
AU  - Cingolani, F.
AU  - Koehler, H.
AU  - Mocarski, E. S.
AU  - Kalman, D.
PY  - 2022
DO  - 10.1101/2022.11.28.518230
UR  - https://www.biorxiv.org/content/10.1101/2022.11.28.518230v1
ID  - 10.1101/2022.11.28.518230
ER  -